pharma · hidradenitis suppurativa (HS) · Hidradenitis Suppurativa · MLTX
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (NASDAQ: is a pharma organization headquartered in Zug, CH. It trades on NYSE under ticker MLTX. Primary therapeutic focus areas include hidradenitis suppurativa (HS), Hidradenitis Suppurativa
Company details
- Status
- Public
- HQ
- Dorfstrasse, 29, Zug 6300, CH
- Founded
- 2021
- Employees
- 133
- Programs
- 13
- Drugs
- 11
- Patents
- 0
Quick answer
MoonLake Immunotherapeutics (NASDAQ: is a pharma organization headquartered in Zug, CH. It trades on NYSE under ticker MLTX. Primary therapeutic focus areas include hidradenitis suppurativa (HS), Hidradenitis Suppurativa, axial spondyloarthritis, psoriatic arthritis, Hidradenitis suppurativa (HS). NovaPharmaNews links 13 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (8), phase 2 (4), phase 1 (1).
Company snapshot
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
- 13 active pipeline program(s) linked via ClinicalTrials.gov.
- 13 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for MoonLake Immunotherapeutics. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for MoonLake Immunotherapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for MoonLake Immunotherapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is MoonLake Immunotherapeutics?
-
Is MoonLake Immunotherapeutics publicly traded?
-
What drugs does MoonLake Immunotherapeutics develop or market?
-
What are the latest developments for MoonLake Immunotherapeutics?
-
What therapeutic areas does MoonLake Immunotherapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.